Infrastructure investor John Laing Group reported an uptick in half-yearly net asset value despite a slump in half-yearly profits as a number of challenges with...

Barclays Capital today reaffirms its overweight investment rating on Segro (LON:SGRO) and raised its price target to 855p (from 755p).

Broker Forecasts data provided by...

Animal genetics company Genus said Stephen Wilson, currently group finance director, had been appointed as Chief Executive with effect from the close of business on...

CRH said it would continue its share buyback programme after the building materials group saw profits jump in the first half of the year, led...

South32 posted a fall in full-year earnings as lower aluminium and thermal coal prices more than offset an increase in production volumes and cost-reduction initiatives....

ViiV Healthcare, a GlaxoSmithKline-Pfizer joint venture, said its injectable HIV treatment had met its primary goal in a clinical trial, reducing the number of treatments...

AstraZeneca said it had agreed to buy a US Food and Drug Administration priority review voucher for $95m in cash from a subsidiary of Swedish...

AstraZeneca said its drug to treat anaemia in non-dialysis-dependent patients suffering from chronic kidney disease had received marketing authorisation in China.

'With this approval for...

Rank group, which operates Mecca Bingo and Grosvenor Casinos, saw a slump in full-year profits as a tough first half offset gains in the second...

Antofagasta said core earnings jumped in the first half of the year amid higher copper sales volumes, though falling copper prices kept a lid on...